UCB Pharma co-led a series A round for the kidney disease-focused drug developer through its UCB Ventures vehicle.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Blood test provider Lumos Diagnostics secured $17.9m and aims to go public in a 2021 IPO that would provide an exit for series A lead investor Planet Innovation.

MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.

10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

The GV-backed health insurance provider has agreed to merge with a special purpose acquisition company in a deal that will value it at $3.7bn.

GV is in line for an exit as the cancer therapy developer set terms for an offering that will raise more than $185m if it floats at the top of its range.

University of Florida's $1m seed fund backed four university spinouts in its inaugural year in sectors including industrial and healthcare.

Eli Lilly will exit the genetic sequencing system provider in a cash-and-share acquisition by 10x Genomics that followed $50m in funding.

University endowments have backed a dollar-denominated venture capital fund from M31 Capital, whose earlier investments include Grail.